Page 1

// Andlauer HEALTHCARE GROUP Andlauer Healthcare Group Reports Second Quarter 2021 Results Toronto , August 11 , 2021 - Andlauer Healthcare Group Inc. ( TSX : AND ) ( " AHG " or the " Company " ) today reported its financial results for the three and six - month periods ended June 30 , 2021 ( " Q2 2021 ” and “ YTD 2021 ” , respectively ) . Q2 2021 Summary • Revenue increased 52.5 % to $ 107.1 million , compared to $ 70.3 million for the three months ended June 30 , 2020 ( " Q2 2020 " ) ; • • Operating income increased 69.5 % to $ 18.8 million , compared to $ 11.1 million in Q2 2020 ; Net income and comprehensive income increased 84.7 % to $ 13.1 million , compared to $ 7.1 million in Q2 2020 ; • EBITDA increased 66.7 % to $ 30.0 million , compared to $ 18.0 million in Q2 2020 ; • EBITDA Margin¹ was 28.0 % , compared to 25.6 % in Q2 2020 ; • • • On March 1 , 2021 , AHG acquired 100 % of Skelton Canada Inc. ( " Skelton ” ) and 49 % of Skelton USA Inc. ( " Skelton USA " ) and an option to acquire the remaining 51 % of Skelton USA for total aggregate consideration of approximately $ 114.7 million , subject to customary working capital adjustments . Skelton contributed approximately $ 10.5 million of revenue during Q2 2021 ; AHG continued to maintain service levels across its operations , while monitoring the safety measures implemented in response to COVID - 19 to prioritize the health and safety of its personnel , clients , and suppliers ; and AHG continued to provide logistics and distribution , specialized transportation and packaging solutions to certain of its manufacturer , third - party logistics provider , wholesaler and government clients that are involved in the Canadian supply of COVID - 19 vaccines and ancillary products . AHG's COVID - 19 vaccine - related revenue comprised approximately 5.0 % of total revenue in Q2 2021 , as the Canadian government secured additional supply of vaccines throughout the quarter . AHG expects to continue to support the supply chain for COVID - 19 vaccines , however it is not clear whether the level of activity experienced in Q2 2021 will be sustained throughout the remainder of 2021 . " We had exceptional performance in both our healthcare logistics and specialized transportation operating segments during the quarter , supported by growth in all of our product lines and a full quarter contribution from our acquisition of Skelton . We are very pleased with the strategic fit of Skelton , which has proven to be a highly complementary addition to our business , ” said Michael Andlauer , Chief Executive Officer of AHG . " We continued to support the distribution of COVID - 19 vaccines and ancillary products to Canadians in the quarter , with activity ramping up significantly as the Canadian government secured more supply . We are proud to be a trusted service provider for this critical mandate and our team's success in providing specialized solutions to our clients involved in the supply of COVID - 19 vaccines further demonstrates the commitment to excellence throughout our operations . "